Publication date: November 2026 Source: Nefrología, Volume 46, Issue 9 Author(s): Lucas Maciel de Almeida Corrêa, Luiggi Kevin Virgino Brandão, Yan Roberth Delmiro Silva, Camilla Cristina Silva Fernandes, Isabela Malerba Pinheiro, Éverton Victor Belmiro da Silva, Gabriela Wander Fossati, Maria Clara do Nascimento Meneses, Sicilia Lins Peixoto Arruda
Sparsentan after approval: Defining the treatment boundary in FSGS without nephrotic syndrome. // Nefrología. – URL: https://www.sciencedirect.com/science/article/pii/S021169952600113X?dgcid=rss_sd_all
Sparsentan after approval: Defining the treatment boundary in FSGS without nephrotic syndrome. Nefrología. https://www.sciencedirect.com/science/article/pii/S021169952600113X?dgcid=rss_sd_all
“Sparsentan after approval: Defining the treatment boundary in FSGS without nephrotic syndrome.” Nefrología.
@article{article94822,
title = {Sparsentan after approval: Defining the treatment boundary in FSGS without nephrotic syndrome},
journal = {Nefrología},
url = {https://www.sciencedirect.com/science/article/pii/S021169952600113X?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez